203 related articles for article (PubMed ID: 16959219)
21. [Inflammation and pain: physiopathologic relations, therapeutic specificities].
Avouac B
Rev Rhum Mal Osteoartic; 1990 Apr; 57(3 ( Pt 2)):267-70. PubMed ID: 2343265
[TBL] [Abstract][Full Text] [Related]
22. Analgesic strategies beyond the inhibition of cyclooxygenases.
Zeilhofer HU; Brune K
Trends Pharmacol Sci; 2006 Sep; 27(9):467-74. PubMed ID: 16876882
[TBL] [Abstract][Full Text] [Related]
23. Acetaminophen, phenacetin and dipyrone do not modulate pressor responses to arachidonic Acid or to pressor agents.
Nossaman BD; Baber SR; Nazim MM; Waldron PR; Hyman AL; Kadowitz PJ
Pharmacology; 2007; 80(4):249-60. PubMed ID: 17627114
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory potential of 2-styrylchromones regarding their interference with arachidonic acid metabolic pathways.
Gomes A; Fernandes E; Silva AM; Pinto DC; Santos CM; Cavaleiro JA; Lima JL
Biochem Pharmacol; 2009 Jul; 78(2):171-7. PubMed ID: 19464432
[TBL] [Abstract][Full Text] [Related]
26. [Current topics in the regulation of prostanoids--3. Prostanoid synthases and prostanoid receptors].
Ohara M; Sawa T
Masui; 1999 Jan; 48(1):42-7. PubMed ID: 10036888
[TBL] [Abstract][Full Text] [Related]
27. Coupling between cyclooxygenases and terminal prostanoid synthases.
Ueno N; Takegoshi Y; Kamei D; Kudo I; Murakami M
Biochem Biophys Res Commun; 2005 Dec; 338(1):70-6. PubMed ID: 16140261
[TBL] [Abstract][Full Text] [Related]
28. Prostanoids and prostanoid receptors in signal transduction.
Bos CL; Richel DJ; Ritsema T; Peppelenbosch MP; Versteeg HH
Int J Biochem Cell Biol; 2004 Jul; 36(7):1187-205. PubMed ID: 15109566
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives.
Cipollone F; Cicolini G; Bucci M
Pharmacol Ther; 2008 May; 118(2):161-80. PubMed ID: 18420277
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
31. Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway.
Stillman MJ; Stillman MT
Geriatrics; 2007 Feb; 62(2):26-34. PubMed ID: 17291140
[TBL] [Abstract][Full Text] [Related]
32. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
Wallace JL; Vong L
Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
[TBL] [Abstract][Full Text] [Related]
33. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis.
Pulichino AM; Rowland S; Wu T; Clark P; Xu D; Mathieu MC; Riendeau D; Audoly LP
J Pharmacol Exp Ther; 2006 Dec; 319(3):1043-50. PubMed ID: 16973887
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Biology of Prostanoids and Drug Discovery.
Zhu L; Zhang Y; Guo Z; Wang M
Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1454-1463. PubMed ID: 32295420
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes.
Kampmann E; Johann S; van Neerven S; Beyer C; Mey J
J Neurochem; 2008 Jul; 106(1):320-32. PubMed ID: 18394023
[TBL] [Abstract][Full Text] [Related]
36. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis.
Chen M; Boilard E; Nigrovic PA; Clark P; Xu D; Fitzgerald GA; Audoly LP; Lee DM
Arthritis Rheum; 2008 May; 58(5):1354-65. PubMed ID: 18438856
[TBL] [Abstract][Full Text] [Related]
37. The pharmacology of selective inhibition of COX-2.
Grosser T
Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandins in the kidney: developments since Y2K.
Nasrallah R; Clark J; Hébert RL
Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
[TBL] [Abstract][Full Text] [Related]
39. The search for new COX-2 inhibitors: a review of 2002 - 2008 patents.
Ramalho TC; Rocha M; da Cunha EF; Freitas MP
Expert Opin Ther Pat; 2009 Sep; 19(9):1193-228. PubMed ID: 19563267
[TBL] [Abstract][Full Text] [Related]
40. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
